VIDEO + ARTICLE IVIG is an FDA-Approved medication. It has been prescribed off-label for Alzheimer’s. Despite recent failures in clinical trials, pharmaceutical companies and academic
Professional care for people with dementias such as Alzheimer’s is commonly referred to as “Long-Term Care”. 70% of people turning age 65 can expect to
VIDEOS & ARTICLE Watch videos on the newly released National Plan to Address Alzheimer’s Disease: 2013 Update. Read about the new timeline for achieving its first goal
A new experimental drug may rescue brain cells just as they begin to become impaired, stopping Alzheimer’s before it is even noticeable. Learn why researchers
Using Deep Brain Stimulation to treat Alzheimer’s is starting to take off. More patients are being added to clinical trials. Learn about the U.S. FDA’s
News on bexarotene demands explaining. In the Alzheimer’s lab, this FDA-approved anti-cancer drug improves memory. Since that is what matters to people, funding is pouring
RADIO & ARTICLE Hear Ronald Peterson, head of the U.S. government’s National Alzheimer’s Project Act, explore the results of 4 new studies on bexarotene (Brand
VIDEO Kathy Sanford is the first person in the USA to have a pacemaker implanted in her brain to treat Alzheimer’s. The pacemaker sends electronic
Dr. Francis Collins, director of the National Institutes of Health (NIH), just gave Americans a dose of good news on Alzheimer’s research. Find out what
Targacept is taking a confident approach in its latest clinical trial. Rather than pitting their new Alzheimer’s drug against a placebo, they are putting it
MEMORY & THINKING are activated by acetyl-choline. Alzheimer’s drugs boost acetyl-choline. Other medications, from allergy to insomnia drugs, may be anti-cholinergic, lowering acetyl-choline. This can spell trouble in dementia. Learn which drugs to avoid and what to look out for.
New Alzheimer’s drugs clear brain plaque made of amyloid-beta. 9 years ago, researchers discovered another Alzheimer’s culprit called amyloid-ETA. Now, they’ve possibly figured out how it works. Learn how balancing these two suspects may hold the key to success in current clinical trials.
The 2 newest Alzheimer’s drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three next ones.
Dr. Richard Taylor has Alzheimer’s and the right attitude!
Swedish researchers find that cholinesterase inhibitors provide cognitive benefits and reduce mortality for up to five years after an Alzheimer’s diagnosis. One medication significantly reduced the risk of developing severe dementia.
Researchers find optimistic people contribute to the health of their partners, staving off risk factors leading to Alzheimer’s disease, other dementias and cognitive decline as they grow old together.
Bringing art and creativity into elder care settings helps families reconnect with loved ones who have dementia. In this moving talk, Anne Bastings shares how.
No spam, only news and updates.
